Caremark Comments on Express Scripts' Second Request from FTC and Recent Delaware Court Rulings.
Business Wire › March 09, 2007
Linked as:
Extract
Caremark Comments on Express Scripts' Second Request from FTC and Recent Delaware Court Rulings.
NASHVILLE, Tenn. -- Caremark Rx, Inc. (NYSE: CMX) issued the following statement regarding the second request by the Federal Trade Commission (FTC) for more information from Express Scripts, Inc. (NASDAQ: ESRX) regarding its proposal to acquire Caremark, which would combine two of only three major national pharmacy benefit managers:
"Despite Express Script...See the full content of this document
Sponsored links
